{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:14:42Z","timestamp":1794964482013,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16321-w","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:13:33Z","timestamp":1759310013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A randomized trial of inulin for bowel symptoms, depression and quality of life in constipation predominant IBS"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-9879","authenticated-orcid":false,"given":"\u00c7a\u011flar","family":"Ak\u00e7al\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-9571","authenticated-orcid":false,"given":"Asl\u0131","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7570-3638","authenticated-orcid":false,"given":"Kadri","family":"Atay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"6","key":"16321_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy, B. E. et al. Bowel disorders. Gastroenterology 150(6), 1393\u20131407. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031 (2016).","journal-title":"Gastroenterology"},{"issue":"6","key":"16321_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman, D. A. & Hasler, W. L. Rome IV\u2014Functional GI disorders: Disorders of gut-brain interaction. Gastroenterology 150(6), 1257\u20131261. https:\/\/doi.org\/10.1053\/j.gastro.2016.03.035 (2016).","journal-title":"Gastroenterology"},{"issue":"1","key":"16321_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber, A. D. et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study. Gastroenterology 160(1), 99\u2013114. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.014 (2021).","journal-title":"Gastroenterology"},{"key":"16321_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/CLEP.S40245","volume":"6","author":"C Canavan","year":"2014","unstructured":"Canavan, C., West, J. & Card, T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 6, 71\u201380. https:\/\/doi.org\/10.2147\/CLEP.S40245 (2014).","journal-title":"Clin. Epidemiol."},{"key":"16321_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond, G. et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur. Arch. Psychiatry Clin. Neurosci. 264, 651\u2013660 (2014).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"16321_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/0019-5545.105520","volume":"55","author":"N Kabra","year":"2013","unstructured":"Kabra, N. & Nadkarni, A. Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J. Psychiatry 55(1), 77\u201380 (2013).","journal-title":"Indian J. Psychiatry"},{"issue":"1","key":"16321_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1186\/s12889-023-16543-5","volume":"23","author":"G Yazbeck","year":"2023","unstructured":"Yazbeck, G. et al. Irritable bowel syndrome (IBS) among Lebanese adults: Unidentified IBS and associated factors. BMC Public Health 23(1), 1589. https:\/\/doi.org\/10.1186\/s12889-023-16543-5 (2023).","journal-title":"BMC Public Health"},{"key":"16321_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.01655","volume":"10","author":"A Lo Presti","year":"2019","unstructured":"Lo Presti, A. et al. Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease. Front. Microbiol. 10, 1\u201314. https:\/\/doi.org\/10.3389\/fmicb.2019.01655 (2019).","journal-title":"Front. Microbiol."},{"issue":"5","key":"16321_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ajg.2013.105","volume":"108","author":"L B\u00f6hn","year":"2013","unstructured":"B\u00f6hn, L., St\u00f6rsrud, S., T\u00f6rnblom, H., Bengtsson, U. & Simr\u00e9n, M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am. J. Gastroenterol. 108(5), 634\u2013641. https:\/\/doi.org\/10.1038\/ajg.2013.105 (2013).","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"16321_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ueg2.12265","volume":"10","author":"C Melchior","year":"2022","unstructured":"Melchior, C., Algera, J., Colomier, E., T\u00f6rnblom, H. & Simr\u00e9n, M. Irritable bowel syndrome with food-related symptoms: Future directions in the clinical management. UEG J. 10(6), 594\u2013600. https:\/\/doi.org\/10.1002\/ueg2.12265 (2022).","journal-title":"UEG J."},{"issue":"11","key":"16321_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.cgh.2015.02.043","volume":"13","author":"BE Lacy","year":"2015","unstructured":"Lacy, B. E. The science, evidence, and practice of dietary interventions in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 13(11), 1899\u20131906. https:\/\/doi.org\/10.1016\/j.cgh.2015.02.043 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"21","key":"16321_CR12","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3748\/wjg.v23.i21.3771","volume":"23","author":"A Cozma-Petru\u0163","year":"2017","unstructured":"Cozma-Petru\u0163, A., Loghin, F., Miere, D. & Dumitra\u015fcu, D. L. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!. World J. Gastroenterol. 23(21), 3771\u20133783. https:\/\/doi.org\/10.3748\/wjg.v23.i21.3771 (2017).","journal-title":"World J. Gastroenterol."},{"key":"16321_CR13","doi-asserted-by":"publisher","first-page":"25877","DOI":"10.3402\/mehd.v26.25877","volume":"26","author":"KP Scott","year":"2015","unstructured":"Scott, K. P., Antoine, J. M., Midtvedt, T. & Van Hemert, S. Manipulating the gut microbiota to maintain health and treat disease. Microbial Ecol. Health Dis. 26, 25877. https:\/\/doi.org\/10.3402\/mehd.v26.25877 (2015).","journal-title":"Microbial Ecol. Health Dis."},{"issue":"6","key":"16321_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/etm.2020.9315","volume":"20","author":"OB B\u0103rboi","year":"2020","unstructured":"B\u0103rboi, O. B., Ciortescu, I., Chiril\u0103, I., Anton, C. & Drug, V. Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review). Exp. Ther. Med. 20(6), 185. https:\/\/doi.org\/10.3892\/etm.2020.9315 (2020).","journal-title":"Exp. Ther. Med."},{"key":"16321_CR15","first-page":"45","volume":"1","author":"N Ilievska","year":"2020","unstructured":"Ilievska, N., Pavlova, V., Kirovska, V., Ilievska, J. & Pavlovska, M. Nutritional and health benefits of inulin functional food and prebiotic. JHED 1, 45\u201348 (2020).","journal-title":"JHED"},{"issue":"1","key":"16321_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/09637486.2016.1212819","volume":"68","author":"A Micka","year":"2017","unstructured":"Micka, A., Siepelmeyer, A., Holz, A., Theis, S. & Sch\u00f6n, C. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: A randomized, double-blind, placebo-controlled trial. Int. J. Food Sci. Nutr. 68(1), 82\u201389. https:\/\/doi.org\/10.1080\/09637486.2016.1212819 (2017).","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"8","key":"16321_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond, G. et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur. Arch. Psychiatry Clin. Neurosci. 264(8), 651\u2013660. https:\/\/doi.org\/10.1007\/s00406-014-0502-z (2014).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"16321_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jad.2020.01.124","volume":"266","author":"CA Simpson","year":"2020","unstructured":"Simpson, C. A., Mu, A., Haslam, N., Schwartz, O. S. & Simmons, J. G. Feeling down? A systematic review of the gut microbiota in anxiety\/depression and irritable bowel syndrome. J. Affect. Disord. 266, 429\u2013446. https:\/\/doi.org\/10.1016\/j.jad.2020.01.124 (2020).","journal-title":"J. Affect. Disord."},{"issue":"5","key":"16321_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-013-0323-7","volume":"15","author":"L \u00d6hman","year":"2013","unstructured":"\u00d6hman, L. & Simr\u00e9n, M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr. Gastroenterol. Rep. 15(5), 1\u20137. https:\/\/doi.org\/10.1007\/s11894-013-0323-7 (2013).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"16321_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1096\/fasebj.27.1_supplement.lb426","volume":"27","author":"V Isakov","year":"2013","unstructured":"Isakov, V., Pilipenko, V., Shakhovskaya, A. & Tutelyan, V. Efficacy of inulin enriched yogurt on bowel habits in patients with irritable bowel syndrome with constipation: A pilot study. FASEB J. 27, 426 (2013).","journal-title":"FASEB J."},{"issue":"2","key":"16321_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3305\/nh.2014.30.2.7565","volume":"30","author":"L Yurrita","year":"2014","unstructured":"Yurrita, L. et al. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr. Hosp. 30(2), 244\u2013252. https:\/\/doi.org\/10.3305\/nh.2014.30.2.7565 (2014).","journal-title":"Nutr. Hosp."},{"issue":"9","key":"16321_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis, S. J. & Heaton, K. W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 32(9), 920\u2013924. https:\/\/doi.org\/10.3109\/00365529709011203 (1997).","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"16321_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/SGA.0b013e3182945881","volume":"36","author":"M Bengtsson","year":"2013","unstructured":"Bengtsson, M., Persson, J., Sj\u00f6lund, K. & Ohlsson, B. Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice. Gastroenterol. Nurs. 36(3), 188\u2013198. https:\/\/doi.org\/10.1097\/SGA.0b013e3182945881 (2013).","journal-title":"Gastroenterol. Nurs."},{"issue":"2","key":"16321_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis, C. Y., Morris, J. & Whorwell, P. J. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol. Ther. 11(2), 395\u2013402. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.142318000.x (1997).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"2","key":"16321_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/a:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J. & Puder, K. L. Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Dig. Dis. Sci. 43(2), 400\u2013411. https:\/\/doi.org\/10.1023\/a:1018831127942 (1998).","journal-title":"Dig. Dis. Sci."},{"key":"16321_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004 (1961).","journal-title":"Arch. Gen. Psychiatry"},{"key":"16321_CR27","unstructured":"Tegin, B. Depresyonda bili\u015fsel \u015femalar. Unpublished doctoral dissertation (Hacettepe University, 1980)."},{"key":"16321_CR28","first-page":"3","volume":"7","author":"N Hisli","year":"1989","unstructured":"Hisli, N. Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi (A reliability and validity study of Beck Depression Inventory in a university student sample). J. Psychol. 7, 3\u201313 (1989).","journal-title":"J. Psychol."},{"issue":"7","key":"16321_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/MCG.0000000000000723","volume":"51","author":"F Azpiroz","year":"2017","unstructured":"Azpiroz, F. et al. Effect of chicory-derived inulin on abdominal sensations and bowel motor function. J. Clin. Gastroenterol. 51(7), 619\u2013625. https:\/\/doi.org\/10.1097\/MCG.0000000000000723 (2017).","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"16321_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1017\/S0029665113001262","volume":"72","author":"K Whelan","year":"2013","unstructured":"Whelan, K. Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders. Proc. Nutr. Soc. 72(3), 288\u2013298. https:\/\/doi.org\/10.1017\/S0029665113001262 (2013).","journal-title":"Proc. Nutr. Soc."},{"issue":"4","key":"16321_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ajcn\/nqy376","volume":"109","author":"B Wilson","year":"2019","unstructured":"Wilson, B., Rossi, M., Dimidi, E. & Whelan, K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: A systematic review and meta-analysis of randomized controlled trials. Trans. Am. J. Clin. Nutr. 109(4), 1098\u20131111. https:\/\/doi.org\/10.1093\/ajcn\/nqy376 (2019).","journal-title":"Trans. Am. J. Clin. Nutr."},{"issue":"2","key":"16321_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.12911","volume":"29","author":"F Azpiroz","year":"2017","unstructured":"Azpiroz, F. et al. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: A randomized, double blind, placebo controlled study. Neurogastroenterol. Motil. 29(2), 1\u20138. https:\/\/doi.org\/10.1111\/nmo.12911 (2017).","journal-title":"Neurogastroenterol. Motil."},{"issue":"8","key":"16321_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/gutjnl-2012-303304","volume":"62","author":"EM Dewulf","year":"2013","unstructured":"Dewulf, E. M. et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62(8), 1112\u20131121. https:\/\/doi.org\/10.1136\/gutjnl-2012-303304 (2013).","journal-title":"Gut"},{"issue":"11","key":"16321_CR34","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1017\/S0007114511002194","volume":"106","author":"SP Verhoef","year":"2011","unstructured":"Verhoef, S. P., Meyer, D. & Westerterp, K. R. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3\u201336 concentrations and energy intake. Br. J. Nutr. 106(11), 1757\u20131762. https:\/\/doi.org\/10.1017\/S0007114511002194 (2011).","journal-title":"Br. J. Nutr."},{"issue":"1","key":"16321_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4082\/kjfm.17.0064","volume":"40","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. A randomized clinical trial of synbiotics in irritable bowel syndrome: Dose-dependent effects on gastrointestinal symptoms and fatigue. Korean J. Fam. Med. 40(1), 2\u20138. https:\/\/doi.org\/10.4082\/kjfm.17.0064 (2019).","journal-title":"Korean J. Fam. Med."},{"issue":"7","key":"16321_CR36","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.3168\/jds.2015-10743","volume":"99","author":"B Matija\u0161i\u0107","year":"2016","unstructured":"Matija\u0161i\u0107, B. et al. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. J. Dairy Sci. 99(7), 5008\u20135021. https:\/\/doi.org\/10.3168\/jds.2015-10743 (2016).","journal-title":"J. Dairy Sci."},{"key":"16321_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ebiom.2016.10.036","volume":"13","author":"LK Stenman","year":"2016","unstructured":"Stenman, L. K. et al. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial. EBioMedicine 13, 190\u2013200. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.036 (2016).","journal-title":"EBioMedicine"},{"issue":"1","key":"16321_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2036.2008.03848.x","volume":"29","author":"EA Williams","year":"2009","unstructured":"Williams, E. A. et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 29(1), 97\u2013103. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03848.x (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"16321_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2036.2008.03911.x","volume":"29","author":"DBA Silk","year":"2009","unstructured":"Silk, D. B. A., Davis, A., Vulevic, J., Tzortzis, G. & Gibson, G. R. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alimentary Pharmacol. Therap. 29(5), 508\u2013518. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03911.x (2009).","journal-title":"Alimentary Pharmacol. Therap."},{"issue":"12","key":"16321_CR40","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00535-011-0454-2","volume":"46","author":"Y Okami","year":"2011","unstructured":"Okami, Y. et al. Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical school students. J. Gastroenterol. 46(12), 1403\u20131410. https:\/\/doi.org\/10.1007\/s00535-011-0454-2 (2011).","journal-title":"J. Gastroenterol."},{"issue":"39","key":"16321_CR41","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.3748\/wjg.v20.i39.14126","volume":"20","author":"HY Qin","year":"2014","unstructured":"Qin, H. Y., Cheng, C. W., Tang, X. D. & Bian, Z. X. Impact of psychological stress on irritable bowel syndrome. World J. Gastroenterol. 20(39), 14126\u201314131 (2014).","journal-title":"World J. Gastroenterol."},{"key":"16321_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1751-0759-2-9","volume":"2","author":"N Sugaya","year":"2008","unstructured":"Sugaya, N. & Nomura, S. Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome. BioPsychoSocial Med. 2, 1\u20136 (2008).","journal-title":"BioPsychoSocial Med."},{"issue":"1","key":"16321_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ajg.2010.453","volume":"106","author":"DA Drossman","year":"2011","unstructured":"Drossman, D. A. Abuse, trauma, and GI illness: \u0130s there a link? Am. J. Gastroenterol. 106(1), 14\u201325 (2011).","journal-title":"Am. J. Gastroenterol."},{"issue":"34","key":"16321_CR44","doi-asserted-by":"publisher","first-page":"12144","DOI":"10.3748\/wjg.v20.i34.12144","volume":"20","author":"RL Soares","year":"2014","unstructured":"Soares, R. L. Irritable bowel syndrome: A clinical review. World J. Gastroenterol. 20(34), 12144\u201312160. https:\/\/doi.org\/10.3748\/wjg.v20.i34.12144 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"16321_CR45","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.3390\/ijerph18083888","volume":"18","author":"HH Chen","year":"2021","unstructured":"Chen, H. H., Hung, C. H., Kao, A. W. & Hsieh, H. F. Exploring quality of life, stress, and risk factors associated with irritable bowel syndrome for female university students in Taiwan. Int. J. Environ. Res. Public Health 18(8), 3888. https:\/\/doi.org\/10.3390\/ijerph18083888 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"11","key":"16321_CR46","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/MEG.0000000000001479","volume":"31","author":"G Vasquez-Rios","year":"2019","unstructured":"Vasquez-Rios, G. et al. Stress and a sedentary lifestyle are associated with irritable bowel syndrome in medical students from Peru: A cross-sectional study. Eur. J. Gastroenterol. Hepatol. 31(11), 1322\u20131327. https:\/\/doi.org\/10.1097\/MEG.0000000000001479 (2019).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"16321_CR47","first-page":"84","volume":"85","author":"VI Pilipenko","year":"2016","unstructured":"Pilipenko, V. I. Using a multicomponent functional food in IBS patients with constipation a comparative controlled study. Vopr. Pitan. 85(2), 84\u201391 (2016).","journal-title":"Vopr. Pitan."},{"issue":"8","key":"16321_CR48","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/jcm11082248","volume":"11","author":"OB B\u0103rboi","year":"2022","unstructured":"B\u0103rboi, O. B., Chiril\u0103, I., Ciortescu, I., Anton, C. & Drug, V. L. Inulin, choline and silymarin in the treatment of irritable bowel syndrome with constipation-randomized case-control study. J. Clin. Med. 11(8), 2248. https:\/\/doi.org\/10.3390\/jcm11082248 (2022).","journal-title":"J. Clin. Med."},{"key":"16321_CR49","doi-asserted-by":"publisher","first-page":"102037","DOI":"10.1016\/j.cdnut.2023.102037","volume":"1","author":"VA Isakov","year":"2023","unstructured":"Isakov, V. A., Pilipenko, V. I., Vlasova, A. V. & Kochetkova, A. A. Evaluation of the efficacy of kombucha-based drink enriched with inulin and vitamins for the management of constipation-predominant irritable bowel syndrome in women: a randomized pilot study. Curr. Dev. Nutr. 1, 102037. https:\/\/doi.org\/10.1016\/j.cdnut.2023.102037 (2023).","journal-title":"Curr. Dev. Nutr."},{"issue":"9","key":"16321_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/jcm7090238","volume":"7","author":"S Balikji","year":"2018","unstructured":"Balikji, S. et al. The association of insomnia, perceived immune functioning, and irritable bowel syndrome complaints. J. Clin. Med. 7(9), 238. https:\/\/doi.org\/10.3390\/jcm7090238 (2018).","journal-title":"J. Clin. Med."},{"issue":"11","key":"16321_CR51","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1185\/03007995.2011.623157","volume":"27","author":"M DiBonaventura","year":"2011","unstructured":"DiBonaventura, M., Sun, S. X., Bolge, S. C., Wagner, J. S. & Mody, R. Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Curr. Med. Res. Opin. 27(11), 2213\u20132222. https:\/\/doi.org\/10.1185\/03007995.2011.623157 (2011).","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"16321_CR52","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","volume":"95","author":"DA Drossman","year":"2000","unstructured":"Drossman, D. A. et al. Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire. Am. J. Gastroenterol. 95(4), 999\u20131007. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.01941.x (2000).","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"16321_CR53","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s11136-011-9985-5","volume":"21","author":"NA Koloski","year":"2012","unstructured":"Koloski, N. A., Boyce, P. M., Jones, M. P. & Talley, N. J. What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Qual. Life Res. 21(5), 829\u2013836. https:\/\/doi.org\/10.1007\/s11136-011-9985-5 (2012).","journal-title":"Qual. Life Res."},{"issue":"6","key":"16321_CR54","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s10620-017-4554-6","volume":"62","author":"R Choghakhori","year":"2017","unstructured":"Choghakhori, R., Abbasnezhad, A., Amani, R. & Alipour, M. Sex-related differences in clinical symptoms, quality of life, and biochemical factors in irritable bowel syndrome. Dig. Dis. Sci. 62(6), 1550\u20131560. https:\/\/doi.org\/10.1007\/s10620-017-4554-6 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"16321_CR55","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1477-7525-11-208","volume":"11","author":"DA Andrae","year":"2013","unstructured":"Andrae, D. A., Patrick, D. L., Drossman, D. A. & Covington, P. S. Evaluation of the \u0131rritable bowel syndrome quality of life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual. Life Outcomes 11, 208. https:\/\/doi.org\/10.1186\/1477-7525-11-208 (2013).","journal-title":"Health Qual. Life Outcomes"},{"issue":"9","key":"16321_CR56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/NMD.0b013e3182a2168a","volume":"201","author":"MB First","year":"2013","unstructured":"First, M. B. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J. Nerv. Ment. Dis. 201(9), 727\u2013729. https:\/\/doi.org\/10.1097\/NMD.0b013e3182a2168a (2013).","journal-title":"J. Nerv. Ment. Dis."},{"issue":"8","key":"16321_CR57","doi-asserted-by":"publisher","first-page":"e13619","DOI":"10.1111\/nmo.13619","volume":"31","author":"I Midenfjord","year":"2019","unstructured":"Midenfjord, I., Polster, A., Sj\u00f6vall, H., T\u00f6rnblom, H. & Simr\u00e9n, M. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterol. Motil. 31(8), e13619. https:\/\/doi.org\/10.1111\/nmo.13619 (2019).","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"16321_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5009\/gnl.2011.5.1.29","volume":"5","author":"HS Cho","year":"2011","unstructured":"Cho, H. S. et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 5(1), 29\u201336. https:\/\/doi.org\/10.5009\/gnl.2011.5.1.29 (2011).","journal-title":"Gut Liver"},{"issue":"1","key":"16321_CR59","first-page":"30","volume":"7","author":"N Farzaneh","year":"2013","unstructured":"Farzaneh, N., Ghobakhlou, M., Moghimi-Dehkordi, B., Naderi, N. & Fadai, F. Anxiety and depression in a sample of Iranian patients with irritable bowel syndrome. Iran J. Psychiatry Behav. Sci. 7(1), 30\u201336 (2013).","journal-title":"Iran J. Psychiatry Behav. Sci."},{"issue":"3","key":"16321_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5056\/jnm16220","volume":"23","author":"C Lee","year":"2017","unstructured":"Lee, C. et al. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: Systematic review and meta-analysis. Neurogastroenterol. Motil. 23(3), 349. https:\/\/doi.org\/10.5056\/jnm16220 (2017).","journal-title":"Neurogastroenterol. Motil."},{"issue":"6","key":"16321_CR61","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.neuropharm.2008.07.016","volume":"55","author":"R Spiller","year":"2008","unstructured":"Spiller, R. Serotonin and GI clinical disorders. Neuropharmacology 55(6), 1072\u20131080. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.07.016 (2008).","journal-title":"Neuropharmacology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16321-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:13:39Z","timestamp":1759310019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16321-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16321-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval of the study was obtained from Izmir Bak\u0131r\u00e7ay University Non-Interventional Clinical Research Ethics Committee (Date: 03\/11\/2021, Decision No: 377). In addition, the study was conducted within the framework of the Helsinki Declaration Principles and informed consent and approval were obtained from the participants.Registration: The study was registered at  (NCT06610188) (24\/09\/2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"34252"}}